125 related articles for article (PubMed ID: 1579219)
1. The acute effects of MK-801 on cerebral blood flow and tissue partial pressures of oxygen and carbon dioxide in conscious and alpha-chloralose anaesthetized rats.
Roussel S; Pinard E; Seylaz J
Neuroscience; 1992; 47(4):959-65. PubMed ID: 1579219
[TBL] [Abstract][Full Text] [Related]
2. Continuous determination of the cerebrovascular changes induced by bicuculline and kainic acid in unanaesthetized spontaneously breathing rats.
Pinard E; Rigaud AS; Riche D; Naquet R; Seylaz J
Neuroscience; 1987 Dec; 23(3):943-52. PubMed ID: 3125492
[TBL] [Abstract][Full Text] [Related]
3. The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation.
Nehls DG; Park CK; MacCormack AG; McCulloch J
Brain Res; 1990 Mar; 511(2):271-9. PubMed ID: 2159360
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat.
Sharkey J; Ritchie IM; Butcher SP; Kelly JS
Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postischemic effects of the NMDA receptor antagonist dizocilpine maleate (MK-801) on collateral cerebral blood flow.
Robertson SC; Wetjen NM; Beer BJ; Loftus CM
J Neurosurg; 1997 Dec; 87(6):927-33. PubMed ID: 9384406
[TBL] [Abstract][Full Text] [Related]
6. [The effect of the NMDA-receptor blocker MK-801 on sensitivity of the respiratory system to carbon dioxide].
Tarakanov IA; Dymetska A; Tarasova NN
Patol Fiziol Eksp Ter; 2005; (2):13-5. PubMed ID: 16078649
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the N-methyl-D-aspartate receptor antagonist MK-801 in conscious rats.
Lewis SJ; Barres C; Jacob HJ; Ohta H; Brody MJ
Hypertension; 1989 Jun; 13(6 Pt 2):759-65. PubMed ID: 2544522
[TBL] [Abstract][Full Text] [Related]
8. Effect of N-methyl-D-aspartate receptor blockade on the control of cerebral O2 supply/consumption balance during hypoxia in newborn pigs.
Williams JA; Colon RJ; Weiss HR
Neurochem Res; 1998 Sep; 23(9):1139-45. PubMed ID: 9712182
[TBL] [Abstract][Full Text] [Related]
9. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke.
Buchan AM; Slivka A; Xue D
Brain Res; 1992 Mar; 574(1-2):171-7. PubMed ID: 1386274
[TBL] [Abstract][Full Text] [Related]
10. Systematic studies on the effects of the NMDA receptor antagonist MK-801 on cerebral blood flow and responsivity, EEG, and blood-brain barrier following complete reversible cerebral ischemia.
Stevens MK; Yaksh TL
J Cereb Blood Flow Metab; 1990 Jan; 10(1):77-88. PubMed ID: 2153692
[TBL] [Abstract][Full Text] [Related]
11. MK-801 pretreatment enhances N-methyl-D-aspartate-mediated brain injury and increases brain N-methyl-D-aspartate recognition site binding in rats.
McDonald JW; Silverstein FS; Johnston MV
Neuroscience; 1990; 38(1):103-13. PubMed ID: 2255390
[TBL] [Abstract][Full Text] [Related]
12. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex.
Kurumaji A; McCulloch J
Brain Res; 1990 Oct; 531(1-2):72-82. PubMed ID: 2289138
[TBL] [Abstract][Full Text] [Related]
13. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats.
McDonald JW; Silverstein FS; Cardona D; Hudson C; Chen R; Johnston MV
Neuroscience; 1990; 36(3):589-99. PubMed ID: 2234402
[TBL] [Abstract][Full Text] [Related]
14. Periventricular anteroventral third ventricle lesions diminish the pressor response produced by systemic injection of the N-methyl-D-aspartate receptor antagonist MK-801.
Whalen EJ; Beltz TG; Lewis SJ; Johnson AK
Brain Res; 1999 Jul; 836(1-2):210-2. PubMed ID: 10415421
[TBL] [Abstract][Full Text] [Related]
15. MK-801 temporarily prevents MPTP-induced acute dopamine depletion and MPP+ elimination in the mouse striatum.
Chan P; Langston JW; Di Monte DA
J Pharmacol Exp Ther; 1993 Dec; 267(3):1515-20. PubMed ID: 8263813
[TBL] [Abstract][Full Text] [Related]
16. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
17. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
Kaur S; Ozer H; Starr M
Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex.
Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J
Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495
[TBL] [Abstract][Full Text] [Related]
19. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane.
Kurumaji A; McCulloch J
J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992
[TBL] [Abstract][Full Text] [Related]
20. Cerebral cortical muscarinic cholinergic and N-methyl-D-aspartate receptors mediate increase in cortical blood flow elicited by chemical stimulation of periaqueductal gray matter.
Nakai M; Maeda M
Neuroscience; 2000; 98(3):449-57. PubMed ID: 10869839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
